Cytokinetics | CYTK - Eps Gewinn Pro Aktie

Aktienkurs
65.92
Täglich Wechseln
0.12 0.18%
Monatlich
8.15%
Jährlich
73.47%
Q2 Prognose
65.24

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 -1.65 -1.36 Apr/30
FY2025Q4 Dec/2025 -1.50 -1.56 -1.26 Feb/24
FY2025Q3 Sep/2025 -2.55 -1.57 -1.36 Nov/05
FY2025Q2 Jun/2025 -1.12 -1.42 -0.08 Aug/07
FY2025Q1 Mar/2025 -1.36 -1.27 -1.33 May/06




Eps Veränderung Datum
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Amgen USD 5.29 0.35 2025-12
Arca Biopharma USD -0.54 0.14 2025-12
Bayer EUR 0.62 0.05 2025-12
Biogen USD 1.99 2.82 2025-12
Brainstorm Cell Therapeutics USD -0.19 0.15 2025-09
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Capricor Therapeutics USD -0.62 0.08 2025-12
Cytokinetics USD -1.5 1.05 2025-12
Eisai JPY 60.94 24.92 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Exelixis USD 0.97 0.19 2025-12
Geron USD -0.05 0.02 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Ligand Pharmaceuticals USD 2.02 1.07 2025-12
Merck USD 2.04 0.54 2025-12
Novartis USD 1.54 0.5 2025-12
Pfizer USD 0.66 0.21 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.53 1.38 2025-12